Characterization of the tumor microenvironment of key suppressive myeloid populations in 11 commonly used preclinical syngeneic cancer models

被引:0
|
作者
Ringgaard, Lars [1 ]
Christensen, Esben [1 ]
Kristensen, Lotte K. [2 ]
Stavnsbjerg, Camilla [1 ]
Kjaer, Andreas [3 ,4 ]
Hansen, Anders E. [1 ]
Andresen, Thomas L. [1 ]
机构
[1] Tech Univ Denmark, Lyngby, Denmark
[2] Minerva Imaging, Copenhagen, Denmark
[3] Rigshosp, Copenhagen, Denmark
[4] Univ Copenhagen, Copenhagen, Denmark
关键词
D O I
10.1158/1538-7445.AM2019-1528
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1528
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Characterization of syngeneic tumor models and their microenvironment for immunotherapeutic approaches
    Carretta, Marco
    Thorseth, Marie Louise
    Agardy, Dennis
    Redondo Garcia, Silvia
    Larsen, Anne Mette Hvid
    Kuczek, Dorota
    Madsen, Daniel
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [2] Characterization of immune cell populations in syngeneic murine tumor models
    Snipstad, Sofie
    Bremnes, Frida
    Haugum, Mats Dehli
    Sulheim, Einar
    CANCER MEDICINE, 2023, 12 (10): : 11589 - 11601
  • [3] Orthotopic syngeneic tumor models for preclinical evaluation of cancer immunotherapy strategies
    Zhang, Juan
    Guo, Sheng
    Wang, Zhensheng
    Li, Zhongliang
    Qiao, Meng
    Shi, Qian
    CANCER RESEARCH, 2016, 76
  • [4] Inhibition of STAT3 by antisense oligonucleotide treatment decreases the immune suppressive tumor microenvironment in syngeneic and GEM tumor models
    Woessner, Rich
    Sah, Vasu
    McCoon, Patricia
    Grosskurth, Shaun
    Deng, Nanhua
    DuPont, Rachel
    Lawson, Deborah
    Pablo, Lourdes
    Reimer, Corinne
    De Velasco, Marco A.
    Uemura, Hirotsugu
    Candido, Juliana
    Lyne, Paul
    CANCER RESEARCH, 2017, 77
  • [5] Targeting Myeloid-derived Suppressive Cells in the Tumor Microenvironment to Enhance the Efficacy of Cancer Immunotherapy
    Huo, Shuping
    Liu, Liang
    Li, Qiaomin
    Wang, Jing
    DISCOVERY MEDICINE, 2020, 30 (161) : 119 - 128
  • [6] CaMKK2 in myeloid cells is a key regulator of the immune-suppressive microenvironment in breast cancer
    Racioppi, Luigi
    Nelson, Erik R.
    Huang, Wei
    Mukherjee, Debarati
    Lawrence, Scott A.
    Lento, William
    Masci, Anna Maria
    Jiao, Yiquin
    Park, Sunghee
    York, Brian
    Liu, Yaping
    Baek, Amy E.
    Drewry, David H.
    Zuercher, William J.
    Bertani, Francesca R.
    Businaro, Luca
    Geradts, Joseph
    Hall, Allison
    Means, Anthony R.
    Chao, Nelson
    Chang, Ching-yi
    McDonnell, Donald P.
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [7] CaMKK2 in myeloid cells is a key regulator of the immune-suppressive microenvironment in breast cancer
    Luigi Racioppi
    Erik R. Nelson
    Wei Huang
    Debarati Mukherjee
    Scott A. Lawrence
    William Lento
    Anna Maria Masci
    Yiquin Jiao
    Sunghee Park
    Brian York
    Yaping Liu
    Amy E. Baek
    David H. Drewry
    William J. Zuercher
    Francesca R. Bertani
    Luca Businaro
    Joseph Geradts
    Allison Hall
    Anthony R. Means
    Nelson Chao
    Ching-yi Chang
    Donald P. McDonnell
    Nature Communications, 10
  • [8] Targeted Inhibition of lncRNA Malat1 Alters the Tumor Immune Microenvironment in Preclinical Syngeneic Mouse Models of Triple-Negative Breast Cancer
    Adewunmi, Oluwatoyosi
    Shen, Yichao
    Zhang, Xiang H. -F.
    Rosen, Jeffrey M.
    CANCER IMMUNOLOGY RESEARCH, 2023, 11 (11) : 1462 - 1479
  • [9] Organotypic Slice Cultures as Preclinical Models of Tumor Microenvironment in Primary Pancreatic Cancer and Metastasis
    Braun, Ruediger
    Lapshyna, Olha
    Eckelmann, Susanne
    Honselmann, Kim
    Bolm, Louisa
    ten Winkel, Meike
    Deichmann, Steffen
    Schilling, Oliver
    Kruse, Charli
    Keck, Tobias
    Wellner, Ulrich
    Bronsert, Peter
    Brandenburger, Matthias
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2021, (172):
  • [10] Characterization of conventional dendritic cell populations in preclinical tumor models using flow cytometry
    Wennerberg, Erik
    Rudqvist, Nils-Petter
    Spada, Sheila
    TUMOR IMMUNOLOGY AND IMMUNOTHERAPY - INTEGRATED METHODS, PT A, 2020, 635 : 139 - 148